During the past decade, Doylestown Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 34 clinical trials were completed, i.e. on average, 91.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 14 clinical trials were completed. i.e. 107.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doylestown Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Abbott Medical Devices" with 8 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doylestown Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Doylestown Hospital" are "Coronary Artery Disease" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Atrial Fibrillation" (5 trials), "Stage IV Breast Cancer AJCC v6 and v7" (5 trials) and "Breast Adenocarcinoma" (4 trials). Many other conditions were trialed in "Doylestown Hospital" in a lesser frequency.

Most popular intervention types in "Doylestown Hospital" are "Drug" (51 trials), "Other" (41 trials), "Biological" (23 trials), "Device" (19 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (11 trials), "Placebo" (10 trials), "Bevacizumab" (8 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Doylestown Hospital" are 68 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Doylestown Hospital". undefined are not yet recruiting, 11 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Doylestown Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Doylestown Hospital, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".

Doylestown Hospital has several departments that took part in Clinical trials: "Doylestown Health Cardiology" - 18 trials, "Central Bucks Cardiology" - 8 trials, "Doylestown Hospital Cancer Center" - 8 trials, "Doylestown Cardiology Associates - VIAA" - 5 trials